Get the Stockscreener App
5.245
1.86%
-0.125
Electrocore Inc stock is traded at $5.245, with a volume of 20,438.
It is down -1.86% in the last 24 hours and up +11.65% over the past month.
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.
See More
Previous Close:
$5.37
Open:
$5.32
24h Volume:
20,438
Relative Volume:
0.14
Market Cap:
$39.77M
Revenue:
$16.03M
Net Income/Loss:
$-18.83M
P/E Ratio:
-1.4986
EPS:
-3.5
Net Cash Flow:
$-14.87M
1W Performance:
-8.03%
1M Performance:
+11.65%
6M Performance:
-61.28%
1Y Performance:
-16.88%
1-Day Range:
$5.1671
$5.49
1-Week Range:
$5.1671
$5.81
52-Week Range:
$4.465
$19.49
Electrocore Inc Stock (ECOR) Company Profile
Name
Electrocore Inc
Sector
Industry
Phone
973-290-0097
Address
200 FORGE WAY, ROCKAWAY
Compare ECOR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ECOR
Electrocore Inc
|
5.335 | 39.77M | 16.03M | -18.83M | -14.87M | -3.50 |
|
ABT
Abbott Laboratories
|
136.96 | 233.03B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
100.87 | 152.13B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
382.03 | 146.41B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
88.47 | 111.53B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
75.86 | 45.62B | 5.54B | 4.18B | 623.10M | 7.00 |
Electrocore Inc Stock (ECOR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-14-20 | Upgrade | BTIG Research | Neutral → Buy |
| Nov-14-19 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| Sep-26-19 | Resumed | Cantor Fitzgerald | Neutral |
| May-30-19 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| May-15-19 | Downgrade | BTIG Research | Buy → Neutral |
| May-09-19 | Initiated | Noble Capital Markets | Outperform |
| Sep-21-18 | Initiated | Cantor Fitzgerald | Overweight |
View All
Electrocore Inc Stock (ECOR) Latest News
Jane Street Group LLC Invests $278,000 in electroCore, Inc. (NASDAQ:ECOR) - Defense World
Trend Tracker for (ECOR) - news.stocktradersdaily.com
electrocore director John Gandolfo acquires $9,018 in shares By Investing.com - Investing.com South Africa
electrocore director John Gandolfo acquires $9,018 in shares - Investing.com
Trading (ECOR) With Integrated Risk Controls - news.stocktradersdaily.com
Global Vagus Nerve Stimulators Market to grow at a CAGR of 9.06% - openPR.com
When Will electroCore, Inc. (NASDAQ:ECOR) Become Profitable? - simplywall.st
Insider Buying: Thomas Errico Acquires 10,000 Shares of electroC - GuruFocus
(ECOR) Trading Report - news.stocktradersdaily.com
INVESTOR ALERTelectroCore, Inc. (ECOR)Bronstein, Gewirtz & Grossman, LLC Reminds of Class Action and Lead Plaintiff Deadline: November 25, 2019 - ACCESS Newswire
ElectroCore anticipates $30M 2025 revenue amid product line expansion - MSN
electroCore Inc (ECOR) Q1 2025 Earnings Call Highlights: Revenue Surge and Strategic Acquisitions Drive Growth - GuruFocus
electroCore Inc (ECOR) Q1 2025 Earnings Call Highlights: Revenue Surge and Strategic ... - Yahoo Finance
Vagus Nerve Stimulators Market Is Booming Worldwide | LivaNova - openPR.com
Bioelectric Medicine Market Rises with Innovation in Neuromodulation Therapies | ElectroCore, Medtronic, Abbott - openPR.com
electroCore, Inc. (NASDAQ:ECOR) Q1 2025 Earnings Call Transcript - Insider Monkey
ElectroCore Reports Strong Q1 Growth and Strategic Expansion - TipRanks
Earnings call transcript: ElectroCore’s Q1 2025 revenue climbs 23%, stock dips - Investing.com
ElectroCore, Inc. (ECOR) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance
electroCore Inc Reports Q1 2025 Earnings: EPS Matches Estimates at -$0.47, Revenue Slightly Misses at $6.7 Million - GuruFocus
electroCore Announces First Quarter 2025 Financial Results - GlobeNewswire
electroCore, Inc. (ECOR): A Bull Case Theory - Insider Monkey
electroCore completes acquisition of neurotechnology solution provider NeuroMetrix - Yahoo
electroCore Acquires NeuroMetrix, Expands Pain Management Portfolio By Investing.com - Investing.com Nigeria
NeuroMetrix finalizes acquisition by electroCore - Investing.com Nigeria
NeuroMetrix finalizes acquisition by electroCore By Investing.com - Investing.com South Africa
ElectroCore Completes Merger With NeuroMetrix - marketscreener.com
ElectroCore completes acquisition of NeuroMetrix - MassDevice
electroCore Completes Acquisition of NeuroMetrix - Medical Product Outsourcing
Electrocore Completes Acquisition Of Neurometrix - marketscreener.com
Electrocore Completes Merger with NeuroMetrix - TipRanks
electroCore Acquires NeuroMetrix, Expands Pain Management Portfolio - Investing.com Australia
ECOR Completes Merger with NeuroMetrix to Bolster Health Solutio - GuruFocus
electroCore Completes Acquisition of NeuroMetrix, Gaining Access - GuruFocus
electroCore Completes Acquisition of NeuroMetrix, Gaining Access to its Quell Platform, Creating Significant Player in Non-Invasive Bioelectronic Technologies | ECOR Stock News - GuruFocus
ECOR Completes Merger with NeuroMetrix to Bolster Health Solutions | ECOR Stock News - GuruFocus
electroCore Completes Acquisition of NeuroMetrix, Gaining Access to its Quell Platform, ... - Bluefield Daily Telegraph
electroCore Completes Acquisition of NeuroMetrix, Gaining Access to its Quell Platform, Creating Significant Player in Non-Invasive Bioelectronic Technologies - GlobeNewswire
electroCore's $4.49/Share NeuroMetrix Buyout Expands Chronic Pain Treatment Portfolio - Stock Titan
Geode Capital Management LLC Reduces Position in electroCore, Inc. (NASDAQ:ECOR) - Defense World
electroCore, Inc. Announces Integration of Truvaga Plus with Apple Health App to Enhance Wellness Tracking - Nasdaq
electroCore's Truvaga™ Now Works with the Apple Health app - The Manila Times
electroCore’s Truvaga™ Now Works with the Apple Health app - GlobeNewswire
(ECOR) Trading Advice - news.stocktradersdaily.com
electroCore to Announce First Quarter March 31, 2025 Financial Results on Wednesday, May 7, 2025 - GlobeNewswire
electroCore Q1 2025 Financial Results: Bioelectronic Leader Hosts Investor Webinar May 7 - Stock Titan
Electrocore Inc Stock (ECOR) Financials Data
Revenue
Net Income
Cash Flow
EPS
Electrocore Inc Stock (ECOR) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Errico Thomas J. | Director |
May 12 '25 |
Buy |
4.77 |
10,000 |
47,735 |
266,401 |
2.67%
0.62%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):